INC Research appoints two to board
Both Mr. Meyers and Mr. Monaghan join the INC Research Board as independent directors and will be Class III directors serving a term ending at the Company’s 2017 Annual Meeting.
Mr. Meyers brings to the INC Research Board more than 25 years of international human resources experience.
Currently Senior Vice President and Chief Human Resources Officer at Hill-Rom, a global medical technologies company, Mr. Meyers held the same role at Hospira until its acquisition by Pfizer in 2015.
Mr. Meyers also has served in senior human resources roles for Mercer/Oliver Wyman, Starbucks Coffee International, The Gymboree Corporation, Walt Disney Imagineering and United Technologies Corporation.
Mr. Meyers holds a Bachelor’s degree with dual majors in International Business and Human Resource Management from the Wharton School of the University of Pennsylvania and an MBA from the Harvard Business School.
Mr. Monaghan brings nearly three decades of professional experience in medical device development, operating management for private equity investors, and manufacturing.
Mr. Monaghan is currently Chairman, President and Chief Executive Officer of Invacare Corporation, a medical device manufacturer for the home and long-term healthcare markets.
Prior to joining Invacare, Mr. Monaghan served as Senior Vice President, Hips and Reconstructive Research for Zimmer Holdings. He also has served in operating management roles for Texas Pacific Group and Cerberus Capital Management.
He started his career at General Electric Company, including roles in aerospace and medical systems.
Mr. Monaghan is a trustee of Cleveland Clinic Avon Lake Hospital. He holds a Bachelor’s degree in Mechanical Engineering from Cornell University, a Master’s degree in Mechanical Engineering from MIT and an MBA from INSEAD in France. ■
LATEST MOVES FROM North Carolina
- G1 Therapeutics appoints Sir Andrew Witty to board
- Select Bancorp promotes Lynn H. Johnson to COO
- Extended Stay America appoints Jodie W. McLean as independent director
- Snyder's-Lance appoints Brian Driscoll as CEO
- BioCryst Pharmaceuticals appoints Robert A. Ingram as chairman
More inside POST